Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study

European Heart Journal

Volumn 26, Issue 15, 2005, Pages 1494-1498

  Cavallini, Claudio ^a   Savonitto, Stefano ^b   Violini, Roberto ^c   Arraiz, Gustavo ^d   Plebani, Mario ^e   Olivari, Zoran ^a   Rubartelli, Paolo ^f   Battaglia, Salvatore ^g   Niccoli, Luigi ^h   Steffenino, Giuseppe ⁱ   Ardissino, Diego ^j  

^a OSPEDALE CA FONCELLO   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d Astra Zeneca Spa   (Italy)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g Clinica Montevergine   (Italy)

^h Civil Hospital   (Italy)

ⁱ S CROCE E CARLE HOSPITAL   (Italy)

^j Maggiore Hospital   (Italy)

more..

Author keywords

Angioplasty; Complications; Enzymes; Prognosis; Stents

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; TROPONIN I;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; ENZYME ASSAY; FEMALE; HEART MUSCLE INJURY; HOSPITAL LABORATORY; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY; UNIVERSITY HOSPITAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; COHORT STUDIES; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; ISOENZYMES; MALE; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; TROPONIN I;

EID: 24144469334     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi173     Document Type: Article

References (24)

1. Nallamothu BK, Bates ER. Periprocedural myocardial infarction and mortality. Causality versus association. J Am Coll Cardiol 2003; 42:1412-1414.
2. Abdelmeguid AE, Topol EJ, Whitlow PL et al. Significance of mild transient release of creatinine kinase-MB fraction after percutaneous coronary intervention. Circulation 1996;94:1528-1536.
3. Kong TQ, Davidson CJ, Meyers SN et al. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997;277:461-466.
4. Akkerhuis KM, Alexander JH, Tardiff BE et al. Minor myocardial damage and prognosis. Are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002;105:554-56.
5. Ioannidis JPA, Karvouni E, Kastrisis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 2003;42:1406-1411.
6. Roe MT, Mahaffey KW, Kilaru R et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J 2004;25:313-321.
7. Kini A, Marmur JD, Kini S et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course. J Am Coll Cardiol 1999;34:663-671.
8. Baim DS, Cutlip DE, Sharma SK et al. Final results of the balloon vs optimal atherectomy trial (BOAT). Circulation 1998;97:322-331.
9. Stone GW, Mehran R, Dangas G et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention. A device-specific analysis of 7174 patients. Circulation 2001;104:642-647.
10. Brener SJ, Ellis SG, Schneider J et al. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 2002;23:869-876.
11. Fuchs S, Kornowski, Mehran R et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000;85:1077-1082.
12. Cantor WJ, Newby LK, Christenson RH et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002;39:1738-1744.
13. Nallamothu BK, Chetcuti S, Mukherjee D et al. Prognostic implication of troponin-I after percutaneous coronary intervention. Am J Cardiol 2003;91:1272-1274.
14. Kini AS, Lee P, Marmur JD et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 2004;93:18-23.
15. Panteghini M, Gerhardt W, Apple FS et al. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001;39:175-178.
16. Califf RM, Abdelmeguid AE, Kuntz RE et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241-251.
17. Ricciardi M, Wu E, Davidson C et al. Visualization of discrete microinfarction after percutaneous coronary interventions associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780-2783.
18. Myocardial infarction redefined. A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-1513.
19. Karvouni E, Katritsis DG, Ioannidis JP. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 2003;41:26-32.
20. Roffi M, Chew DP, Mukherjee D et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001;104:2767-2771.
21. Hamm CW, Ravkilde J, Gerhardt W et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-150.
22. Baim DS, Wahr D, George B et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290.
23. Ellis SG, Chew D, Chan A et al. Death following creatine kinase-MB elevation after coronary intervention. Identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularisation, ventricular function and probable benefit of statin therapy. Circulation 2002;106:1205-1210.
24. Serruys PW, de Feyter P, Macaya C et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. JAMA 2002;287:3215-3222.